linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Glenmark Pharmaceuticals Ltd.
 
Source DateBoard Meeting DateDetails
12 May 202523 May 2025 Final Dividend & Audited Results
03 Feb 202514 Feb 2025 Quarterly Results
30 Oct 202414 Nov 2024 Quarterly Results
31 Jul 202414 Aug 2024 Quarterly Results
14 May 202424 May 2024 Audited Results & Final Dividend
30 Jan 202414 Feb 2024 Quarterly Results
31 Oct 202310 Nov 2023 Quarterly Results
31 Jul 202311 Aug 2023 Quarterly Results
03 May 202319 May 2023 Final Dividend & Audited Results
13 Jan 202310 Feb 2023 Quarterly Results
02 Nov 202211 Nov 2022 Quarterly Results
29 Jul 202210 Aug 2022 Quarterly Results
18 May 202227 May 2022 Final Dividend & Audited Results & Quarterly Results
02 Feb 202211 Feb 2022 Quarterly Results
01 Nov 202112 Nov 2021 Quarterly Results
05 Aug 202113 Aug 2021 Quarterly Results
19 May 202128 May 2021 Quarterly Results & Final Dividend & Audited Results
01 Feb 202112 Feb 2021 Quarterly Results & Inter alia, , to consider opportunistic tenders or buybacks of any part of its Singapore listed foreign currency convertible bonds, being, its U.S.$200 million (as on date outstanding U.S.$ 113.5 million) 2 per cent resettable onward starting equity linked securities due June 28, 2022 issuep in 2016 ("FCC Bonds"), based on market opportunities and conditions from time to time and to delegate powers to operations committee. The Operations Committee, based on market opportunities and conditions, will hold meetings to consider and approve the terms and conditions of any tenders or buybacks.
27 Oct 202006 Nov 2020 Quarterly Results
05 Aug 202014 Aug 2020 Quarterly Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.